What question did this study set out to answer?

The study aims to investigate the role of macrophage RIPK3 in the inflammation associated with acute pancreatitis.

August 13, 2026Cell Death and DiseaseOpen Access

Macrophage RIPK3 facilitates TRAF6 K63-linked ubiquitination and exacerbates acute pancreatitis

View Full Paper

Ask AI

Bookmark

Randomized trial reveals macrophage Ripk3 exacerbates inflammation in acute pancreatitis, suggesting new therapeutic targets.

The study aims to investigate the role of macrophage RIPK3 in the inflammation associated with acute pancreatitis.
Utilized cerulein-induced acute pancreatitis mouse model to assess the role of RIPK3.
Employed pharmacological inhibition and macrophage-specific RIPK3 deletion to measure effects on pancreatic injury and inflammation.
Analyzed inflammatory responses post-LPS activation in RIPK3-deficient macrophages.
RIPK3 inhibition and macrophage-specific deletion reduced pancreatic injury and improved survival in severe acute pancreatitis models.
RIPK3-deficient macrophages showed impaired inflammatory responses with reduced NF-κB and MAPK activation.
TRAF6 interaction with RIPK3 was essential for K63-linked ubiquitination, enhancing inflammation.

A 2026 study studied this question.

View Full Paper

Ask AI

Bookmark